Principal Financial Group Inc. Makes New $13.38 Million Investment in Astrana Health, Inc. (NASDAQ:ASTH)

Principal Financial Group Inc. purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 230,975 shares of the company's stock, valued at approximately $13,383,000. Principal Financial Group Inc. owned approximately 0.41% of Astrana Health at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. State Street Corp purchased a new stake in shares of Astrana Health during the 3rd quarter worth approximately $91,966,000. Geode Capital Management LLC purchased a new stake in Astrana Health in the third quarter valued at $58,995,000. FMR LLC acquired a new position in Astrana Health in the third quarter valued at $48,413,000. SteelPeak Wealth LLC purchased a new position in shares of Astrana Health during the third quarter worth about $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of Astrana Health during the third quarter worth about $30,251,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on ASTH shares. KeyCorp initiated coverage on Astrana Health in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a report on Thursday, October 3rd. Macquarie raised shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. Robert W. Baird increased their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. Finally, TD Cowen started coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a "buy" rating and a $66.00 price objective on the stock. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $65.17.

Astrana Health Stock Performance

Shares of Astrana Health stock traded down $0.81 on Friday, reaching $32.72. 235,126 shares of the stock were exchanged, compared to its average volume of 218,009. The firm has a market capitalization of $1.84 billion, a PE ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13. Astrana Health, Inc. has a 1-year low of $32.21 and a 1-year high of $63.20. The business has a fifty day moving average price of $44.45 and a two-hundred day moving average price of $47.62. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same period in the prior year, the business posted $0.47 EPS. As a group, research analysts anticipate that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.